排序方式: 共有1条查询结果,搜索用时 0 毫秒
1
1.
Debnath Bhuniya Rajendra K. Kharul Atul Hajare Nadim Shaikh Sandeep Bhosale Sandip Balwe Fouzia Begum Siddhartha De Sonalee Athavankar Dhananjay Joshi Vamsi Madgula Kaushal Joshi Amol A. Raje Ashwinkumar V. Meru Amol Magdum Kasim A. Mookhtiar Rashmi Barbhaiya 《Bioorganic & medicinal chemistry letters》2019,29(2):238-243
Conceptual design and modification of urea moiety in chemotype PF-3845/04457845, the bench marking irreversible inhibitor of fatty acid amide hydrolase (FAAH), led to discovery of a novel nicotinamide-based lead 12a having reversible mechanism of action. Focused SAR around the pyridine heterocycle (Ar) in 12a (Tables 1 and 2) resulted into four shortlisted compounds, (?)-12a, (?)-12i, (?)-12l–m. The required (?)-enantiomers were obtained via diastereomeric resolution of a novel chiral dissymmetric intermediate 15. Based on comparative profile of FAAH potency, metabolic stability in liver microsome, liability of inhibiting major hCYP450 isoforms, rat PK, and brain penetration ability, two SAR optimized compounds, (?)-12l and (?)-12m, were selected for efficacy study in rat model of chemotherapy-induced peripheral neuropathy (CIPN). Both the compounds exhibited dose related antihyperalgesic effects, when treated with 3–30?mg/kg po for 7?days. The effects at 30?mg/kg are comparable to that of PF-04457845 (10?mg/kg) and Tramadol (40?mg/kg). 相似文献
1